HERCESSI
NDC 69448-016, Trastuzumab-strf, injection, powder, lyophilized, for solution, from Accord BioPharma Inc..
- Product NDC
- 69448-016
- Status
- Listed
- Labeler
- Accord BioPharma Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761346
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69448-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRASTUZUMAB-STRF420 mg/20mL
Pharmacologic classes
HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69448-016-11 | 69448001611 | 1 VIAL, MULTI-DOSE in 1 CARTON (69448-016-11) / 20 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/285d2142-5bfa-401c-9246-7de21c4451afMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69448-016
Use it
Look up 69448-016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69448-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69448-016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.